Complain about a product or service

Gene Therapy May Offer Hope For Alzheimer's Patients

April 25, 2005
Experimental gene therapy on a small number of people with Alzheimer's disease suggests it may be effective in slowing the disease's effects, according to researchers. The study is detailed in the journal Nature Medicine.

• Too Much Selenium Can Increase Cholesterol • Money Management Problems Could Be Alzheimer's Warning • Mediterranean Diet Linked With Lower Risk Of Alzheimer's Disease • High Cholesterol In Midlife Raises Risk Of Late-Life Dementia • Some Blood Pressure Drugs May Help Protect Against Dementia • Study Suggests Earlier Alzheimer's Treatment • Alzheimer's Cases Rise Among "Oldest Old" • Researchers Find Caffeine Effective Alzheimer’s Treatment • Landmark Alzheimer's Drug Cleared For Clinical Trials • Blood Test May Diagnose Alzheimer's • Diet May Be Factor in Memory Retention • Insulin May Combat Alzheimer's • Moderate Drinking Can Reduce Risks of Alzheimer's • Daily Pill Said To Stop Alzheimer's • Low Levels of 'Good Cholesterol' Linked to Memory Loss, Dementia Risk • Chemical in Celery May Fight Alzheimer's • Dementia Linked To Obesity • Studies Find Link Between Diabetes and Alzheimer's --- • Index to all Alzheimer's stories

In the clinical trial, eight patients in the early stages of Alzheimer's received gene therapy. After 22 months, six of the eight had a slower rate of cognitive loss, as measured by standard medical testing.

For the trial, the researchers used a gene that controls production of nerve growth factor, a naturally occurring protein that protects brain cells.

Lead author of the study, Mark H. Tuszynski of the University of California, San Diego, said the substance had been used in treatment of other diseases, with mostly negative effects. He said this was the first use of the protein - or of any gene - to treat Alzheimer's. Tuszynski is also a principal of Ceregene, the company holding the rights to this particular gene therapy technique.

Gene therapy has yet to yield any real results in the decade and a half it's been tried, but Tuszynski and his colleagues say there is reason to be hopeful in this case.

They say by using the gene to trigger natural growth factor production in the brain, precisely at the points where it's needed, the brain may be able to withstand the disease that is relentlessly degenerative, and inevitably fatal.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Share		Follow us on Twitter.

Back to the top |